Scientific Advisory Board
Biota's Scientific Advisory Board provide an independent periodical, technical review of Biota's research and clinical programs.
Dr John Domagala
Dr Domagala has over 30 years of experience in pharmaceutical anti-infective research and has held senior management positions in the US pharmaceutical industry. His former roles included Executive Director Infectious Diseases, Pfizer Global Research and Senior Director Warner-Lambert/Park Davis. During his career he has led multi-disciplined project teams in every aspect of drug discovery and development with successful progression of 10 prospective drugs into clinical development and 3 New Drug Applications. He has a PhD in medicinal chemistry.
Professor Jeffery (Jeff) Errington
Professor Errington is a renowned scientist in the field of microbial cell and molecular biology and is a Fellow of the Royal Society. Jeff is the Director of the Institute for Cell and Molecular Biosciences and the Director of the Centre for Bacterial Cell Biology at Newcastle University. He is a world authority on the biochemical pathways responsible for bacterial replication, an essential pre-requisite to the successful development of novel antibacterial drugs.
Dr Rob Fenton
Dr Fenton,Research Strategy Director, Institute of Biomedical Engineering, London has over 30 years of experience within the pharmaceutical industry and is widely considered a world authority on influenza and an expert on animal model systems in drug discovery. Dr Fenton was instrumental to the discovery and development of Relenza and has experience in diverse areas of pharmaceutical R&D, including DMPK, toxicology, pharmacy, clinical, commercial and IP. His discovery experience includes antiviral research on hepatitis C, herpes, papilloma and various respiratory viruses as well as oncology. Positions he has held in GSK include Director of Virology; Section Head, Virus and Vaccine Systems; Lab Head, Cancer Research. He is currently an independent consultant and is employed by the Institute of Biomedical Engineering, Imperial College, London as their Research Strategy Director.
Professor Harry Greenberg
Professor Greenberg Stanford, Professor of Medicine and Microbiology and Immunology at Stanford University School of Medicine. Prior appointments include Senior Vice President for Research and Chief Scientific Officer, Aviron (now MedImmune Vaccines). He is a distinguished researcher with particular interests in viral diseases of the GI tract, liver and respiratory tract. He is responsible for seminal work in several areas including those of hepatitis and gastrointestinal disease (particularly that of rotavirus). He has published over 30 papers and holds 4 patents. In addition to his many prestigious appointments he is a member of the MedImmune Scientific Advisory Board.
Professor Doug Richman
Professor Richman, University of California, San Diego, USA is Professor of Pathology and Medicine at UC and Director of the Centre for AIDS Research at UCSD. He is an accomplished infectious disease physician and, although he has broad interests beyond HIV, for the past 20 years has developed renown in the field of HIV pathogenesis. His laboratory is credited with being the first to report HIV drug resistance.
Professor Noel Roberts
Professor Noel Roberts, visiting Professor in Biosciences, University of Cardiff, Wales, and former Roche Products Ltd, UK (retired). Professor Roberts has devoted the majority of his distinguished career to drug discovery within the pharmaceutical industry, principally in the antiviral and anti-inflammatory fields. Professor Roberts led a biological team responsible for the discovery of saquinavir (the first HIV protease inhibitor), and was closely involved in work leading to the registration and approval of Invirase (saquinavir), Tamiflu, Valcyte and Fuzeon. He was the recipient of the Roche International R&D Prize in 1995, the Society of Medicines Research Award for Drug Discovery in 1997 and the Pharmaceutical Research and Manufacturers of America Discoverers Award in 1999. His various roles have included Head of Product Support for Viral Diseases, Head of Antiviral Biology and Team Leader in Anti-inflammatory Biology Research.